In this study, we examined the role and potential therapeutic implication of SHP-1/p-Lyn signaling in DLBCL. We highlight the importance of the axis formed by the tumor suppressor SHP-1 and the oncogenic p-Lyn in DLBCL. This evidence concerns the gene PTPN6 and diffuse large B-cell lymphoma.